FOXM1 and breast cancer: The compounds bind directly to FOXM1 and affect FOXM1 stability, decrease the cellular level of FOXM1, effectively suppress proliferation and increase apoptosis of FOXM1-containing human breast cancer cells, and block the expression of FOXM1-regulated genes.